(Q47347620)

14 January 2018

title

Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4. (English)

1 reference

14 January 2018

author

Gustavo Pacheco-López

6

1 reference

14 January 2018

Wolfgang Langhans

5

object named as

W Langhans

1 reference

14 January 2018

M A Labouesse

1

1 reference

14 January 2018

U Stadlbauer

2

1 reference

14 January 2018

E Weber

3

1 reference

14 January 2018

M Arnold

4

1 reference

14 January 2018

publication date

1 December 2012

1 reference

14 January 2018

Journal of Neuroendocrinology

published in

1 reference

14 January 2018

volume

24

1 reference

14 January 2018

issue

12

1 reference

14 January 2018

page(s)

1505-1516

1 reference

14 January 2018

Global burden of obesity in 2005 and projections to 2030.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Obesity - an indication for GLP-1 treatment? Obesity pathophysiology and GLP-1 treatment potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Glucagon-like peptide-1: a potent regulator of food intake in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

GLP-1 and energy balance: an integrated model of short-term and long-term control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Glucagon and glucagon-like peptide receptors as drug targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Comparative effects of the long-acting GLP-1 receptor ligands, liraglutide and exendin-4, on food intake and body weight suppression in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Brain activation following peripheral administration of the GLP-1 receptor agonist exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Peripheral glucagon-like peptide-1 (GLP-1) and satiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Neuroanatomy of extrinsic afferents supplying the gastrointestinal tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Evidence that intestinal glucagon-like peptide-1 plays a physiological role in satiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

The vagus nerve, food intake and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Experimental dissociation of neural circuits underlying conditioned avoidance and hypophagic responses to lithium chloride.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Peripheral protein immunization induces rapid activation of the CNS, as measured by c-Fos expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Circulating GLP-1 and CCK-8 reduce food intake by capsaicin-insensitive, nonvagal mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Multiple neural systems controlling food intake and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Gut feelings: the emerging biology of gut-brain communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Subdiaphragmatic vagal afferent innervation in activation of an opioidergic antinociceptive system in response to colorectal distension in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Subdiaphragmatic vagotomy promotes nociceptive sensitivity of deep tissue in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Central infusion of glucagon-like peptide-1-(7-36) amide (GLP-1) receptor antagonist attenuates lithium chloride-induced c-Fos induction in rat brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Role of the area postrema in three putative measures of motion sickness in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

The amygdalar circuit that acquires taste aversion memory differs from the circuit that extinguishes it

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Glucagon-like peptide-1 receptor stimulation increases blood pressure and heart rate and activates autonomic regulatory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.2012.02364.X

10.1111/J.1365-2826.2012.02364.X

21 January 2018

Identifiers

DOI

1 reference

14 January 2018

PubMed ID

22827554

1 reference

14 January 2018